Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Treatment of melanoma in-transit metastases confined to the limb
A. M.M. Eggermont
, P. M. Schlag
Research output
:
Contribution to journal
›
Article
›
peer-review
64
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of melanoma in-transit metastases confined to the limb'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In-transit Metastasis
100%
Isolated Limb Perfusion
100%
Melanoma Treatment
100%
Melphalan
50%
Perfusion
50%
Primary Tumor
33%
Interferon-α (IFN-α)
33%
Tumor Necrosis Factor-α
33%
Overall Response Rate
33%
Response Rate
33%
Isolated Limb Infusion
33%
Intra-arterial Chemotherapy
33%
Intralesional Injection
33%
Tumor
16%
Europe
16%
Effective Therapy
16%
Multiple Lesions
16%
Survival Benefit
16%
Melanoma
16%
Interferon-γ
16%
Local Control
16%
Local Relapse
16%
Complete Response Rate
16%
% Response
16%
Hyperthermia
16%
Locoregional Treatment
16%
Excision
16%
Melanoma Patients
16%
Surgical Excision
16%
Local Tumor Control
16%
Regional Chemotherapy
16%
Perfusion System
16%
Carbon Dioxide Laser
16%
Systemic Metastasis
16%
Recurrence-free Interval
16%
Small Nodules
16%
Recurrent Melanoma
16%
Tourniquet
16%
Satellitosis
16%
Laser Evaporation
16%
Extracorporeal Perfusion
16%
Subcutaneous Nodules
16%
Medicine and Dentistry
In-Transit Metastasis
100%
Limb
100%
Limb Perfusion
100%
Melanoma
100%
Melphalan
50%
Neoplasm
33%
Primary Tumor
33%
Recurrent Disease
33%
Tumor Necrosis Factor
33%
Infusion
33%
Intralesional Drug Administration
33%
Interferon
33%
Intraarterial Drug Administration
33%
Disease
16%
Metastatic Carcinoma
16%
Hyperthermia
16%
Gamma Interferon
16%
Carbon Dioxide Laser
16%
Regional Perfusion
16%
Subcutaneous Nodule
16%
Extracorporeal Circulation
16%